NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Contract (Products)
Duration
15 month
Value
£33M
Sector
HEALTH
Published
02 Feb 2024
Delivery
01 Feb 2024 to 30 Apr 2025
Deadline
27 Nov 2023 13:00

Concepts

Location

Geochart for 1 buyers and 3 suppliers
NHS England
Amgen
Alexion Pharmaceuticals
Samsung Bioepis
+−
Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

1 buyer

3 suppliers

Description

Project Title: NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024 Offer reference number: CM/PHR/22/5693 Period of framework: 1 February 2024 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Award Detail

1 Amgen (Cambridge)
  • Value: £32,653,000
2 Alexion Pharmaceuticals (Uxbridge)
  • Value: £32,653,000
3 Samsung Bioepis (Brentford)
  • Value: £32,653,000

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

Document No. 10 - Pharmacy Purchasing Points List - CM-PHR-22-5693 Document No. 10 - Pharmacy Purchasing Points List - CM-PHR-22-5693.xls FTS 031590-2023 - OPPORTUNITY NOTICE - Eculizumab FTS 031590-2023 - OPPORTUNITY NOTICE - Eculizumab.pdf Transparency Award Schedule - CM_PHR_22_5693 Transparency Award Schedule - CM_PHR_22_5693.pdf Document No. 03 - Framework Agreement and Terms and Conditions Branded Document No. 03 - Framework Agreement and Terms and Conditions Branded.docx CMPHR225693 - Parties Appointed to the framework - Eculizumab CMPHR225693 - Parties Appointed to the framework - Eculizumab.xlsx

Reference

Domains